Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.59
Delayed Data
As of Mar 28
 -0.04 / -0.52%
Today’s Change
6.15
Today|||52-Week Range
9.88
-11.44%
Year-to-Date

Today’s Trading

Previous close7.63
Today’s open7.64
Day’s range7.50 - 7.64
Volume560,463
Average volume (3 months)280,861
Market cap$601.4M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+24.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.13-1.45%
NVTAInvitae Corp-0.02-0.19%
ENZEnzo Biochem Inc-0.22-2.54%
PTIProteostasis Therape...-0.35-3.06%
Data as of 4:02pm ET, 03/28/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs